CRL Charles River Laboratories
- Official Name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Headquarters: 251 Ballardvale St, WILMINGTON, MA, 01887 US
- CEO: James Foster
- Website: criver.com
- Key Investor: VANGUARD GROUP INC | 11.94%
- Dedicated Investor: LAURUS GLOBAL EQUITY MANAGEMENT INC. | 9.06%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Won by 8.761 | 2.318 - (6.443) | ||
| 2025-07-21 | 2 | Lost by 4.569 | (5.111) - (0.542) | ||
| 2025-07-28 | 3 | Won by 11.623 | 17.569 - 5.946 | ||
| 2025-07-29 | 2R | Won by 1.718 | (0.948) - (2.666) | ||
| 2025-08-04 | 4 | Lost by 10.020 | (6.711) - 3.309 | ||
| 2025-08-07 | 1R | Won by 0.990 | 1.048 - 0.058 | ||
| 2025-08-11 | 5 | Lost by 9.753 | (5.695) - 4.058 | ||
| 2025-08-12 | 3R | Lost by 13.717 | 2.100 - 15.817 | ||
| 2025-08-18 | 6 | Won by 4.283 | 6.659 - 2.376 | ||
| 2025-08-20 | 1R | Won by 2.138 | 0.613 - (1.525) | ||
| 2025-08-21 | 2R | Lost by 1.974 | (2.385) - (0.411) | ||
| 2025-08-25 | 7 | Lost by 0.094 | 3.848 - 3.942 | ||
| 2025-09-01 | 8 | Lost by 1.691 | (0.507) - 1.184 | ||
| 2025-09-03 | 2R | Won by 0.903 | 0.679 - (0.224) | ||
| 2025-09-08 | 9 | Won by 1.258 | (0.805) - (2.063) | ||
| 2025-09-15 | 10 | Lost by 3.758 | (6.380) - (2.622) | ||
| 2025-09-17 | 3R | Won by 0.370 | 0.743 - 0.373 | ||
| 2025-09-22 | 11 | Lost by 2.005 | 1.137 - 3.142 | ||
| 2025-09-29 | 12 | Lost by 6.668 | (4.119) - 2.549 | ||
| 2025-10-01 | QF | Won by 3.537 | 8.801 - 5.264 | ||
| 2025-10-06 | 13 | Won by 13.900 TOTW | 16.747 - 2.847 | ||
| 2025-10-13 | 14 | Lost by 8.867 | (2.379) - 6.488 | ||
| 2025-10-15 | SF | Won by 2.614 | 0.357 - (2.257) | ||
| 2025-10-20 | 15 | Won by 7.600 TOTW | 8.204 - 0.604 | ||
| 2025-10-22 | F | Lost by 0.820 | (0.593) - 0.227 |
Latest News
Yahoo - 2026-10-16
Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles River Labor...
Yahoo - 2026-10-15
State Street Corporation Q3 2026 Earnings Call Summary
Moby summary of State Street Corporation's Q3 2026 earnings call
Benzinga - 2026-10-14
Here’s How Much You Would Have Made Owning Charles River Stock In The Last 20 Years
Charles River (NYSE:CRL) has outperformed the market over the past 20 years by 1.14% on an annualized basis producing an average annual return of 10.1...
Yahoo - 2026-10-14
Charles River partners with Magellan Stem Cells on cell therapy
The partnership focuses on biologics quality control as well as viral and release testing under cGMP standards.
Yahoo - 2026-10-14
Healthcare Contract Research Organization (CRO) - Global Strategic Business Report: Secure Share of US$63.3 Billion Market by 2032 as IQVIA, ICON, Charles River, and Syneos Health Accelerate AI Trials
Outsource clinical trials and leverage AI, decentralized models and regulatory expertise to cut costs, accelerate drug development and expand patient ...
Benzinga - 2026-10-13
Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $340
Morgan Stanley analyst Ricky Goldwasser maintains Charles River (NYSE:CRL) with a Overweight and raises the price target from $300 to $340.
Yahoo - 2026-10-13
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
WILMINGTON, Mass., October 13, 2026--Charles River Laboratories International, Inc. (NYSE: CRL) and Magellan Stem Cells, a private Australian biotech ...
Benzinga - 2026-10-13
Charles River Laboratories International Partners With Magellan Stem Cells For Development, Clinical Advancement Of Stem Cell-Based Therapies, Regenerative Medicine Solutions
Charles River Laboratories International, Inc. (NYSE: CRL) and Magellan Stem Cells, a private Australian biotech and cell-therapy firm, announce their...
Yahoo - 2026-10-12
1 S&P 500 Stock to Target This Week and 2 We Question
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down b...
Yahoo - 2026-10-12
Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera
Boost ROI with AI-led design, automated high-throughput screening, customizable libraries, local production and diversified sourcing to cut costs and ...
Show more
Yahoo - 2026-10-09
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
ChartMill - 2026-10-08
Stay informed with the top movers within the S&P500 index on Thursday.
Yahoo - 2026-10-07
PGNY or CRL: Which Is the Better Value Stock Right Now?
Yahoo - 2026-10-07
Charles River Gains 75.8% in a Year: What's Driving the Rally?
Yahoo - 2026-10-06
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Benzinga - 2026-10-06
Charles River Laboratories and Autolomous Launch Apollo Orchestrate To Digitize Laboratory Execution Through autoloMATE Integration
ChartMill - 2026-10-05
Uncover the latest developments among S&P500 stocks in today's session.
ChartMill - 2026-10-05
Which S&P500 stocks are moving on Monday?
Yahoo - 2026-10-02
Charles River Laboratories (CRL) Stock Fair Value Rises After Analyst Day Target Increases
Fintel - 2026-10-02
Charles River Laboratories International Consensus Price Target Increased by 11.46% to $307.39
Benzinga - 2026-09-30
Here's How Much $1000 Invested In Charles River 15 Years Ago Would Be Worth Today
Benzinga - 2026-09-30
UBS Reinstates Buy on Charles River, Announces $357 Price Target
Yahoo - 2026-09-29
Demand Stabilization Fuels Charles River Laboratories International’s (CRL) Recovery
Yahoo - 2026-09-29
NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
Benzinga - 2026-09-28
Jefferies Maintains Buy on Charles River, Raises Price Target to $340
Yahoo - 2026-09-27
Is Charles River Laboratories Stock Outperforming the S&P 500?
Yahoo - 2026-09-25
Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan
Benzinga - 2026-09-25
Deutsche Bank Maintains Buy on Charles River, Raises Price Target to $320
Benzinga - 2026-09-25
TD Cowen Maintains Buy on Charles River, Raises Price Target to $325
Benzinga - 2026-09-25
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $330
Benzinga - 2026-09-25
RBC Capital Maintains Outperform on Charles River, Raises Price Target to $322
Benzinga - 2026-09-25
Barclays Maintains Overweight on Charles River, Raises Price Target to $330
SeekingAlpha - 2026-09-25
Charles River Laboratories: Positive Investor Day Is Fully Priced In
Benzinga - 2026-09-25
Mizuho Maintains Neutral on Charles River, Raises Price Target to $295
Benzinga - 2026-09-25
Baird Maintains Outperform on Charles River, Raises Price Target to $334
Yahoo - 2026-09-25
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
Yahoo - 2026-09-25
Charles River Laboratories (CRL) Stock Still Seems Reasonable Despite Rapid Cell Banking Launch
Yahoo - 2026-09-24
Why Charles River Laboratories (CRL) Stock Is Up Today
ChartMill - 2026-09-24
Discover which S&P500 stocks are making waves on Thursday.
ChartMill - 2026-09-24
Explore the top gainers and losers within the S&P500 index in today's session.
SeekingAlpha - 2026-09-24
Charles River Laboratories International, Inc. (CRL) Analyst/Investor Day Transcript
Benzinga - 2026-09-24
S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today
Yahoo - 2026-09-24
Drug Safety Market Forecasts Growth from $7.12B (2026) to $10.21B by 2032, Profiling IQVIA, ICON, Charles River, Oracle & Parexel
Yahoo - 2026-09-24
Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day
Benzinga - 2026-09-24
Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday
SeekingAlpha - 2026-09-24
Charles River Laboratories International, Inc. (CRL) Analyst/Investor Day - Slideshow
Benzinga - 2026-09-24
Charles River Laboratories International Reiterates FY26 Revenue, Non-GAAP Earnings Outlook, Expects FY30 Organic Revenue Growth In Range Of 5% To 7%
Yahoo - 2026-09-23
Capitalize on Pharmacokinetics Outsourcing Disruption as Charles River, Labcorp, WuXi AppTec, Eurofins and Sygnature Compete to Dominate Drug Development ROI
Yahoo - 2026-09-23
3 Unpopular Stocks Walking a Fine Line
ChartMill - 2026-09-22
These S&P500 stocks are moving in today's session
Yahoo - 2026-09-22
Disrupt Drug Discovery and Secure R&D ROI: Benchmark Fragment-Based Strategies from Astex, Evotec, Charles River, Schrödinger and Vernalis Through 2030
Yahoo - 2026-09-21
Charles River’s (CRL) Vaccine Push Meets A Bumpy Quarter
Yahoo - 2026-09-21
Charles River’s (CRL) New Automation Push Meets Old Margin Problems
Yahoo - 2026-09-18
Can Charles River Laboratories International (CRL) Justify Its Valuation On Its Rapid Cell Banking Launch?
Yahoo - 2026-09-18
PGNY vs. CRL: Which Stock Is the Better Value Option?
Yahoo - 2026-09-18
What Is Charles River Laboratories International (CRL) Signaling With Its Faster Cell Banking Platform?
Yahoo - 2026-09-18
Charles River Laboratories International (CRL) Stock Fair Value Rises After Analysts Lift Targets
Yahoo - 2026-09-17
What Charles River Laboratories International (CRL)'s Accelerated, NGS-Enabled Cell Banking Platform Means For Shareholders
Yahoo - 2026-09-17
Why Charles River Laboratories (CRL) Stock Is Trading Up Today
Yahoo - 2026-09-17
Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines
Yahoo - 2026-09-16
3 Reasons to Sell CRL and 1 Stock to Buy Instead
SeekingAlpha - 2026-09-15
Charles River Laboratories International, Inc. (CRL) Presents at 2026 Global Healthcare Conference Transcript
SeekingAlpha - 2026-09-14
Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Yahoo - 2026-09-14
Beat the Market the Zacks Way: FIGS, Microsoft, Amphenol in Focus
Yahoo - 2026-09-11
Are Medical Stocks Lagging Amgen (AMGN) This Year?
Benzinga - 2026-09-11
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $320
Yahoo - 2026-09-08
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
SeekingAlpha - 2026-09-08
Health Care's Next Act: Tailwinds Emerging Across R&D Cycle
Yahoo - 2026-09-01
Here's Why You Should Hold Charles River Stock in Your Portfolio Now
Yahoo - 2026-09-01
Is This the Right Time to Add CRL Stock to Your Portfolio?
Fintel - 2026-08-28
Charles River Laboratories International (CRL) Price Target Increased by 17.31% to 274.25
Yahoo - 2026-08-27
Animal Testing and Non-Animal Alternative Testing Market Outlook 2025-2035 - Featuring Profiles of Charles River Laboratories, Labcorp, and Eurofins Scientific
Yahoo - 2026-08-26
Is Wall Street Bullish or Bearish on Charles River Laboratories Stock?
Benzinga - 2026-08-25
Here's How Much $100 Invested In Charles River 15 Years Ago Would Be Worth Today
Yahoo - 2026-08-25
3 Inflated Stocks We Approach with Caution
SeekingAlpha - 2026-08-24
Tracking John Rogers' Ariel Investments Portfolio - Q2 2026 Update
Yahoo - 2026-08-22
Does Charles River (CRL)–Medigen Vaccine Work Sharpen the Case for Its Complex Biologics Edge?
Yahoo - 2026-08-21
Why Is Charles River Laboratories International (CRL) Pushing Deeper Into Vaccine Development?
Yahoo - 2026-08-21
CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?
Yahoo - 2026-08-21
Are Options Traders Betting on a Big Move in Charles River Stock?
Yahoo - 2026-08-21
Charles River Gains 88.6% in a Year: What's Driving the Rally?
Yahoo - 2026-08-20
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
Benzinga - 2026-08-20
Charles River Laboratories And Medigen Vaccine Biologics Collaborate On Characterization And Validation Of Virus Seed Bank For MVC's Next-Gen Multivalent Enterovirus Vaccine
Yahoo - 2026-08-16
1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges
Benzinga - 2026-08-14
If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today
Yahoo - 2026-08-12
Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-11
CRAI Jumps 20% in 3 Months as Demand Broadens Across Key Practices
Yahoo - 2026-08-10
International Markets and Charles River (CRL): A Deep Dive for Investors
Benzinga - 2026-08-10
TD Cowen Maintains Buy on Charles River, Raises Price Target to $300
Benzinga - 2026-08-07
Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $300
Benzinga - 2026-08-07
This SpaceX Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Fintel - 2026-08-06
JP Morgan Upgrades Charles River Laboratories International (CRL)
Benzinga - 2026-08-06
RBC Capital Maintains Outperform on Charles River, Raises Price Target to $282
Yahoo - 2026-08-06
Charles River Laboratories International Q2 Earnings Call Highlights
Benzinga - 2026-08-06
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $300
Benzinga - 2026-08-06
This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Benzinga - 2026-08-06
JP Morgan Upgrades Charles River to Overweight, Raises Price Target to $310
Yahoo - 2026-08-05
Charles River (CRL) Is Up 11.0% After Raising Adjusted EPS Outlook Amid Divestiture-Driven GAAP Losses – Has The Bull Case Changed?
Yahoo - 2026-08-05
Charles River Laboratories International Inc (CRL) (Q2 2026) Earnings Call Highlights: First ...
Yahoo - 2026-08-05
Sector Update: Healthcare Stocks Rise Late Afternoon
ChartMill - 2026-08-05
Wednesday's session: top gainers and losers in the S&P500 index
ChartMill - 2026-08-05
Top S&P500 movers in Wednesday's session
Yahoo - 2026-08-05
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
Yahoo - 2026-08-05
CRL Q2 Earnings and Revenues Top, '26 View Up, Stock Up in Pre-Market
ChartMill - 2026-08-05
Which S&P500 stocks are gapping on Wednesday?
Benzinga - 2026-08-05
Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today
SeekingAlpha - 2026-08-05
Charles River Laboratories International, Inc. (CRL) Q2 2026 Earnings Call Transcript
Benzinga - 2026-08-05
Charles River Says Biotech Demand Is Back — Bookings Hit Four-Year High
Yahoo - 2026-08-05
Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?
ChartMill - 2026-08-05
Wondering what's happening in today's S&P500 pre-market session?
ChartMill - 2026-08-05
Charles River Laboratories (NYSE:CRL) Tops Q2 Estimates and Raises Full-Year Outlook
CNBC - 2026-08-05
Stocks making the biggest moves midday: Alphabet, SpaceX, Shopify, Newmont, Insulet, AMD & more
Yahoo - 2026-08-05
Charles River Laboratories’s (NYSE:CRL) Q2 CY2026 Sales Top Estimates, Stock Soars
Yahoo - 2026-08-05
Charles River Laboratories Announces Second-Quarter 2026 Results
SeekingAlpha - 2026-08-05
Charles River: Near-Term Inflection But Long-Term Risk
Benzinga - 2026-08-05
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday
SeekingAlpha - 2026-08-05
Charles River Laboratories International, Inc. 2026 Q2 - Results - Earnings Call Presentation
Benzinga - 2026-08-05
Charles River Lowers FY2026 GAAP EPS Guidance from $5.35-$5.85 to $3.05-$3.35 vs $6.24 Est
Benzinga - 2026-08-05
Charles River Raises FY2026 Adj EPS Guidance from $10.80-$11.30 to $11.15-$11.45 vs $11.12 Est; Raises FY2026 Sales Guidance from $3.794B-$3.854B to $3.879B-$3.920B vs $3.850B Est
Benzinga - 2026-08-05
Charles River Q2 Adj. EPS $3.02 Beats $2.74 Estimate, Sales $1.004B Beat $975.687M Estimate
Yahoo - 2026-08-04
Can These 3 MedTech Stocks Hit Targets This Earnings Season?
Yahoo - 2026-07-30
Charles River Prepares to Report Q2 Earnings: What's in Store?
Yahoo - 2026-07-30
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Yahoo - 2026-07-29
Align Technology to add directors, launch review after deal with Elliott
Yahoo - 2026-07-29
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
SeekingAlpha - 2026-07-29
IQVIA: A Great Business At The Wrong Price (Rating Downgrade)
ChartMill - 2026-07-28
These S&P500 stocks are gapping in today's session
Benzinga - 2026-07-28
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
Yahoo - 2026-07-24
HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised
ChartMill - 2026-07-23
Which S&P500 stocks are gapping on Thursday?
ChartMill - 2026-07-23
These S&P500 stocks that are showing activity before the opening bell on Thursday.
Yahoo - 2026-07-23
3 Profitable Stocks with Warning Signs
Yahoo - 2026-07-22
3 Healthcare Stocks We Approach with Caution
ChartMill - 2026-07-20
What's going on in today's session: S&P500 movers
Yahoo - 2026-07-20
Charles River Laboratories Earnings Preview: What to Expect
Fintel - 2026-07-20
CLSA Downgrades Charles River Laboratories International (CRL)
Yahoo - 2026-07-17
Charles River Laboratories International (CRL) Expands Cell Therapy Work, Is The Stock Still Undervalued?
Yahoo - 2026-07-16
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
Yahoo - 2026-07-16
Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?
Yahoo - 2026-07-16
Does Arovella CAR-iNKT NGS Partnership Deepen Charles River’s Cell Therapy Moat or Stretch CRL Too Thin?
Yahoo - 2026-07-15
Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call
Yahoo - 2026-07-15
Cell-Based Assay Services for Preclinical Use Only Global Market Report 2026 Released — Profiles Charles River, Labcorp, Eurofins and Evotec
Yahoo - 2026-07-13
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
Benzinga - 2026-07-13
Keysight To Rally Over 24%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga - 2026-07-13
Mizuho Maintains Neutral on Charles River, Raises Price Target to $230
Benzinga - 2026-07-09
Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $260
Yahoo - 2026-07-08
ICON Stock and the CRO Trends Shaping Its Next Growth Phase
Yahoo - 2026-07-07
Medpace Growth Trends Show How CRO Demand Is Shifting in 2026
Yahoo - 2026-07-07
3 Overrated Stocks We’re Skeptical Of
Yahoo - 2026-07-06
Medpace Stock Outlook Turns on Backlog Quality and Cancellations
Yahoo - 2026-07-04
Why is Morgan Stanley Bullish on Charles River Laboratories International, Inc. (CRL) as a Top Stock to Buy According to Ariel Investment?
Yahoo - 2026-07-02
3 Reasons to Avoid CRL and 1 Stock to Buy Instead
Yahoo - 2026-07-01
LH or CRL: Which Is the Better Value Stock Right Now?
Yahoo - 2026-07-01
Is This the Right Time to Hold CRL Stock in Your Portfolio?
CNBC - 2026-06-30
Anthropic launches Claude Science
SeekingAlpha - 2026-06-29
ValuEngine Weekly Market Summary And Commentary
CNBC - 2026-06-29
Tuesday's big stock stories: What’s likely to move the market in the next trading session
Yahoo - 2026-06-26
Is Charles River (CRL) Quietly Redefining Its Moat Through Lilly’s AI-Driven TuneLab Collaboration?
Yahoo - 2026-06-22
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
Yahoo - 2026-06-22
How Is Charles River Laboratories’ Stock Performance Compared to Other Health Care Stocks?
Yahoo - 2026-06-19
Charles River collaborates with Lilly TuneLab platform
Yahoo - 2026-06-18
Morgan Stanley sees writing on wall for key drug research stocks
Yahoo - 2026-06-18
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
Fintel - 2026-06-17
Morgan Stanley Upgrades Charles River Laboratories International (CRL)
Yahoo - 2026-06-17
Stocks Mixed Ahead of FOMC Meeting Results
Yahoo - 2026-06-17
Stocks Supported by Chip Stock Strength and Strong US Retail Sales
Yahoo - 2026-06-17
Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls
Yahoo - 2026-06-17
Morgan Stanley favors Charles River Over IQVIA in CRO sector reset
Benzinga - 2026-06-17
This Charles River Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Benzinga - 2026-06-17
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga - 2026-06-17
Morgan Stanley Upgrades Charles River to Overweight, Raises Price Target to $220
Yahoo - 2026-06-16
1 S&P 500 Stock on Our Buy List and 2 We Brush Off
Yahoo - 2026-06-15
LH vs. CRL: Which Stock Is the Better Value Option?
Yahoo - 2026-06-12
Charles River Labs (CRL) Pulled Back Due to AI Disruption Fears
Yahoo - 2026-06-10
Reasons Why You Should Hold Charles River Stock in Your Portfolio
Yahoo - 2026-06-04
Assessing Charles River Laboratories (CRL) Valuation After Mixed Returns And Contrasting Undervaluation Signals
Yahoo - 2026-06-04
The Zacks Analyst Blog Highlights Stantec, CBIZ and Charles River
Yahoo - 2026-06-04
Zacks Industry Outlook Highlights Stantec, CBIZ and Charles River
SeekingAlpha - 2026-06-03
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
SeekingAlpha - 2026-06-03
Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
SeekingAlpha - 2026-06-02
Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Benzinga - 2026-06-01
10 Health Care Stocks With Whale Alerts In Today's Session
Fintel - 2026-05-29
CLSA Upgrades Charles River Laboratories International (CRL)
Yahoo - 2026-05-29
Best Buy downgrade, Dell upgraded: Wall Street's top analyst calls
Benzinga - 2026-05-29
CLSA Upgrades Charles River to Outperform, Raises Price Target to $219
ChartMill - 2026-05-27
Which S&P500 stocks are moving on Wednesday?
Yahoo - 2026-05-26
Are Wall Street Analysts Bullish on Charles River Laboratories Stock?
SeekingAlpha - 2026-05-25
Tracking John Rogers' Ariel Investments Portfolio - Q1 2026 Update
Yahoo - 2026-05-24
Is Charles River (CRL) Quietly Recasting Its Moat Around AI Pathology And Cell Therapy Services?
Yahoo - 2026-05-20
Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers
Yahoo - 2026-05-18
The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call
SeekingAlpha - 2026-05-16
What Moved Markets This Week
Yahoo - 2026-05-13
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Benzinga - 2026-05-13
Charles River And MEDIPOST Enter Into Strategic, Non-Exclusive MOU To Collaborate On GMP-Compliant Testing To Advance Cell Therapy Development And Commercialization
Yahoo - 2026-05-11
CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion
Finnhub - 2026-05-11
Charles River Laboratories International, Inc. Accelerates Digital Pathology with Ai-Powered End-To-End Workflow
Yahoo - 2026-05-09
Is It Time To Rethink Charles River Laboratories (CRL) After Its Recent Price Rebound?
Yahoo - 2026-05-09
Charles River Laboratories International Q1 Earnings Call Highlights
Benzinga - 2026-05-08
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
Benzinga - 2026-05-08
Barclays Maintains Overweight on Charles River, Raises Price Target to $220
Benzinga - 2026-05-08
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $220
SeekingAlpha - 2026-05-07
Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript
Yahoo - 2026-05-07